Perspective on key issues
Novartis believes transparency and partnership are key drivers toward finding long-term, sustainable solutions to global health challenges.
To this end, Novartis maintains relationships with key public health stakeholders including government officials, politicians, regulatory authorities, international organizations, nongovernmental organizations and patient groups. We engage in major policy debates, sharing the company’s perspective on public health issues and striving for open and constructive interaction.
As part of our ongoing commitment to transparency, we state our position on various issues affecting our business. Please feel free to contact Public Affairs at public.affairs@novartis.com.
Access to medicines in the developing world ›
Disclosure of clinical research results ›
Ethical promotion of pharmaceuticals ›
Genetic testing (Employment) ›
Health Technology Assessment ›
Naming requirements for Biosimilars ›
Nanotechnology-based medicine ›
Patient group interaction and support ›
Pharmaceuticals in the environment ›
India Glivec® / Gleevec® Patent Case
Find out the Novartis perspective and see our demonstrated commitment to providing access to medicines by visiting our information center.